Description

Total Laparoscopic Hysterectomy (TLH) has become a widely accepted minimally invasive procedure for the management of various gynecological conditions such as fibroids, abnormal uterine bleeding, and early-stage malignancies. Despite its advantages—reduced postoperative pain, shorter hospital stay, and quicker recovery—TLH carries a potential risk of ureteric injury due to the close anatomical relationship between the uterus and ureters. To mitigate this risk, the use of an illuminated ureteric catheter has emerged as a valuable innovation, significantly enhancing surgical safety. The ureters are delicate tubular structures that transport urine from the kidneys to the bladder. During TLH, especially in complex cases involving distorted pelvic anatomy, endometriosis, or large fibroids, identifying and preserving the ureters becomes challenging. Ureteric injuries, although uncommon, can lead to serious complications such as urinary fistula, sepsis, and long-term morbidity. Therefore, ensuring clear visualization of the ureters is critical. An illuminated ureteric catheter is a specialized device inserted into the ureter prior to surgery. It emits light along the course of the ureter, allowing surgeons to easily identify its pathway during laparoscopy. This real-time visualization serves as a guiding landmark, helping surgeons avoid inadvertent injury while dissecting surrounding tissues. The illumination is particularly beneficial in cases with dense adhesions or altered anatomy, where conventional identification techniques may be insufficient. At World Laparoscopy Hospital, the integration of illuminated ureteric catheters into TLH procedures reflects a commitment to patient safety and surgical excellence. Surgeons are trained to adopt advanced technologies that enhance precision and reduce complications. The use of this device not only improves intraoperative confidence but also contributes to better surgical outcomes. The technique involves cystoscopic insertion of the catheter into one or both ureters before beginning the laparoscopic procedure. Once activated, the catheter emits a visible glow that can be seen through the laparoscopic camera. This allows continuous monitoring of ureteric position throughout the surgery. As a result, critical steps such as uterine artery ligation, cardinal ligament dissection, and vault closure can be performed with greater assurance. Clinical experience has demonstrated that the use of illuminated ureteric catheters reduces the incidence of ureteric injury and shortens operative time in complex cases. It also serves as an excellent teaching tool for trainees, helping them understand ureteric anatomy and spatial orientation during minimally invasive surgery. However, like any adjunctive technique, it should be used judiciously. Routine use in all TLH cases may not be necessary, but it is highly recommended in high-risk situations such as previous pelvic surgeries, severe endometriosis, or oncological procedures. Proper training and familiarity with the device are essential to maximize its benefits. In conclusion, the illuminated ureteric catheter represents a significant advancement in enhancing the safety of Total Laparoscopic Hysterectomy. By providing clear, real-time visualization of the ureters, it minimizes the risk of injury and improves surgical precision. Institutions like World Laparoscopy Hospital continue to lead in adopting such innovations, ensuring that patients receive the highest standard of minimally invasive surgical care.